Alario Anthony F, Strong Travis D, Pizzirani Stefano
VCA Capital Area Veterinary Emergency and Specialty, 1 Intervale Road, Concord, NH 03301, USA.
Lloyd Veterinary Medical Center, Iowa State University College of Veterinary Medicine, 1600 16th Street, Ames, IA 50011, USA.
Vet Clin North Am Small Anim Pract. 2015 Nov;45(6):1235-59, vi. doi: 10.1016/j.cvsm.2015.06.004. Epub 2015 Aug 28.
Glaucoma is a painful and often blinding group of ocular diseases for which there is no cure. Although the definition of glaucoma is rapidly evolving, elevated intraocular pressure (IOP) remains the most consistent risk factor of glaucoma in the canine patient. Therapy should be aimed at neuroprotection. The mainstay of therapy focuses on reducing IOP and maintaining a visual and comfortable eye. This article discusses the most current ocular hypotensive agents, focusing on their basic pharmacology, efficacy at lowering IOP, and recommended use in the treatment of idiopathic canine glaucoma.
青光眼是一组痛苦且常导致失明的眼部疾病,目前尚无治愈方法。尽管青光眼的定义在迅速演变,但眼内压升高(IOP)仍是犬类患者青光眼最一致的危险因素。治疗应旨在神经保护。治疗的主要重点是降低眼内压并维持眼睛的视觉功能和舒适度。本文讨论了最新的降眼压药物,重点介绍其基本药理学、降低眼内压的疗效以及在特发性犬青光眼治疗中的推荐用法。